- Home
- BYND vs HRTX Comparison
BYND vs HRTX Comparison
Compare BYND & HRTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BYND
- HRTX
- Stock Information
- Founded
- BYND 2009
- HRTX 1983
- Country
- BYND United States
- HRTX United States
- Employees
- BYND N/A
- HRTX N/A
- Industry
- BYND Packaged Foods
- HRTX Biotechnology: Pharmaceutical Preparations
- Sector
- BYND Consumer Staples
- HRTX Health Care
- Exchange
- BYND Nasdaq
- HRTX Nasdaq
- Market Cap
- BYND 214.6M
- HRTX 206.9M
- IPO Year
- BYND 2019
- HRTX 1987
- Fundamental
- Price
- BYND $2.73
- HRTX $1.21
- Analyst Decision
- BYND Sell
- HRTX Strong Buy
- Analyst Count
- BYND 4
- HRTX 2
- Target Price
- BYND $3.00
- HRTX $4.50
- AVG Volume (30 Days)
- BYND 2.0M
- HRTX 1.4M
- Earning Date
- BYND 11-05-2025
- HRTX 11-11-2025
- Dividend Yield
- BYND N/A
- HRTX N/A
- EPS Growth
- BYND N/A
- HRTX N/A
- EPS
- BYND N/A
- HRTX N/A
- Revenue
- BYND $301,353,000.00
- HRTX $149,694,000.00
- Revenue This Year
- BYND N/A
- HRTX $10.62
- Revenue Next Year
- BYND $0.73
- HRTX $12.99
- P/E Ratio
- BYND N/A
- HRTX N/A
- Revenue Growth
- BYND N/A
- HRTX 9.78
- 52 Week Low
- BYND $2.23
- HRTX $1.04
- 52 Week High
- BYND $7.60
- HRTX $2.68
- Technical
- Relative Strength Index (RSI)
- BYND 52.75
- HRTX 28.21
- Support Level
- BYND $2.29
- HRTX $1.25
- Resistance Level
- BYND $2.60
- HRTX $1.27
- Average True Range (ATR)
- BYND 0.14
- HRTX 0.06
- MACD
- BYND 0.06
- HRTX 0.01
- Stochastic Oscillator
- BYND 80.73
- HRTX 8.70
About BYND Beyond Meat Inc.
Beyond Meat Inc is a provider of plant-based meat company offering a portfolio of revolutionary plant-based meats. It builds meat directly from plants, an innovation that enables consumers to experience the taste, texture and other sensory attributes of popular animal-based meat products while enjoying the nutritional and environmental benefits of eating plant-based meat product It has products such as burgers, sausage, ground beef, jerky, meatballs and chicken. The company generates revenue from sales of its products to the customers across mainstream grocery, mass merchandiser, club store, convenience store and natural retailer channels and various food-away-from-home channels, including restaurants, foodservice outlets and schools, mainly in the United States.
About HRTX Heron Therapeutics Inc.
Heron Therapeutics Inc is a commercial-stage biotechnology company. It is focused on improving the lives of patients by developing treatments that address some of the unmet patient needs. The company's product portfolio consists of APONVIE, SUSTOL, ZYNRELEF, and CINVANTI.